Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | -19.81 % |
3 Month Return | -45.15 % |
1 Year Return | -61.54 % |
Market Stats | |
Previous Close | ₹55.65 |
Open | ₹52.90 |
Volume | 12.00K |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹65.11Cr |
P/E Ratio | 25.77 |
PEG Ratio | 7.36 |
Market Cap | ₹207.23 Cr |
P/B Ratio | 1.37 |
EPS | 4.71 |
Dividend Yield | 0 |
Sector | Pharmaceuticals |
ROE | 10.19 |
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
NA | ₹207.23 Cr | 49.33% | 0.79 | ₹7 Cr | ₹339 Cr | |
NA | ₹10.56 Cr | 219.49% | 0.50 | NA | NA | |
BUY | ₹6,511.04 Cr | 14.02% | 0.62 | ₹48 Cr | ₹717 Cr | |
NA | ₹28.64 Cr | 67.38% | 0.50 | NA | NA | |
NA | ₹42.25 Cr | -16.52% | 0.50 | NA | NA |
Organisation | Medicamen Organics Ltd |
Headquarters | |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Key events for Medicamen Organics Ltd
Medicamen Organics Ltd shares surged 10% after signing an MoU to expand into the French West African market, forming Grande Etoile Pharmaceuticals Ltd. The company expects significant revenue growth, with a 14% increase in revenue and a 147% rise in net profit for FY23-24.
Medicamen Biotech Soars After EU GMP Certification - 12 Sep, 2024
Medicamen Biotech shares surged over 14% following the receipt of EU GMP certification for its Bhiwadi facility. The stock has shown significant gains recently, advancing 16.15% in the past week and 20% in the last month, despite being down 28.39% over the past year. As of September 12, 2024, shares were trading at Rs 485.85, reflecting strong market interest.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
FII Holding Up
Foreign Institutions have increased holdings from 0.00% to 2.22% in Jun 2024 quarter
Retail Holding Up
Retail Investor have increased holdings from 0.00% to 32.79% in Jun 2024 quarter
Price Dip
In the last 1 month, MEDIORG stock has moved down by -19.8%
Promoter Holding Down
Promoters have decreased holdings from 81.21% to 59.69% in Jun 2024 quarter
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 59.69% | ||
Foreign Institutions | 2.22% | 0.00 | |
Mutual Funds | 0% | 0.00 | |
Retail Investors | 32.79% | 0.00 | |
Others | 5.3% |
Bearish
Neutral
Bullish
Medicamen Organics Ltd is currently in a Bearish trading position according to technical analysis indicators.
Medicamen Organics Ltd (MEDIORG) share price today is ₹55
Medicamen Organics Ltd is listed on NSE
Medicamen Organics Ltd is not listed on BSE
Today’s traded volume of Medicamen Organics Ltd(MEDIORG) is 12.00K.
Today’s market capitalisation of Medicamen Organics Ltd(MEDIORG) is ₹65.11Cr.
Medicamen Organics Ltd(MEDIORG | Price |
---|---|
52 Week High | ₹159.4 |
52 Week Low | ₹52.9 |
Medicamen Organics Ltd(MEDIORG) share price is ₹55. It is down -65.50% from its 52 Week High price of ₹159.4
Medicamen Organics Ltd(MEDIORG) share price is ₹55. It is up 3.97% from its 52 Week Low price of ₹52.9
Medicamen Organics Ltd(MEDIORG | Returns |
---|---|
1 Day Returns | -0.65% |
1 Month Returns | -19.81% |
3 Month Returns | -45.15% |
1 Year Returns | -61.54% |